Tag: Treatment
IIT Madras researchers identify enhanced drug delivery method for eye treatments
Researchers demonstrate how mild laser-induced convection can enhance the delivery of drugs injected into the eye to the retina
Twist Bioscience and MedGenome partner to launch HOPE for Rare Diseases...
Collaboration offers affordable whole exome sequencing for underprivileged patients to improve rare disease diagnosis and treatment in India
Merck and Rashtreeya Sikshana Samithi Trust to enhance rural cancer care...
New partnership expands cancer screening and diagnostic support to 600 villages, supports research and treatment
Health Ministry to set up Technical Expert Group for SMA, budget...
Dr. L Swasticharan, Additional Director General at the Directorate General of Health Services (DGHS), announced these developments at SMArtCon2024
From Bench to Bedside: Streamlining the Journey of Personalized Therapies in India
Integrated lab-clinic facilities are particularly beneficial for therapies that require seamless collaboration between laboratory research and clinical applications
Sun Pharma to present results of the Phase III PIVOTAL trial...
PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy
LVPEI’s ‘WHITATHON’ Run raises funds for childhood eye cancer
Annual charity running event gathers community support to combat Retinoblastoma, emphasizing early detection and treatment
Intracellular protein delivery using hybrid nanotubes could revolutionize cancer treatment
The hybrid nanotube stamp system revolutionizes precision medicine with high efficiency and cell viability rates for cancer treatment
Apollo Proton Cancer Centre introduces India’s first Robotic Surgery Program for...
Breakthrough surgeries mark a significant advancement in cancer treatment, offering new hope for patients battling advanced ovarian cancers
Myopia cases among urban Indian children has tripled in last 20...
Doctors predict a concerning rise in myopia cases among urban Indian children aged 5-15 years, with one-third projected to be affected by 2030 and half by 2050